Basic Information

Symbol
circGCN1L1
RNA Class
circRNA
Alias
GCN1 Activator Of EIF2AK4 KIAA0219 GCN1L1 GCN1L GCN1 (General Control Of Amino-Acid Synthesis 1, Yeast)-Like 1 General Control Of Amino-Acid Synthesis 1-Like Protein 1 GCN1, EIF2 Alpha Kinase Activator Homolog GCN1 EIF-2-Alpha Kinase Activator Homolog Stalled Ribosome Sensor GCN1 Translational Activator GCN1 GCN1-Like Protein 1 HsGCN1 Peroxisome Proliferator Activated Receptor Interacting Complex Protein GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 (Yeast) GCN1 General Control Of Amino-Acid Synthesis 1-Like 1 EIF-2-Alpha Kinase Activator GCN1 PRIC295
Location (GRCh37)
12:120567080-120632513 UCSC Genome Browser
Location (GRCh38)
Host gene
GCN1L1
Host category
mRNA
Forensic tag(s)
Other applications
External database

Transcripts

ID Type Location (GRCh37) Location (GRCh38) Length GC content
hsa_GCN1L1_0016400 Exon-Exon chr12:120600874-120615555 chr12:120163070-120177752 1378 nt 0.5414
hsa_GCN1L1_0016500 Exon-Exon chr12:120600874-120616562 chr12:120163070-120178759 1513 nt 0.5440
hsa_GCN1L1_0016600 Exon-Exon chr12:120600874-120622046 chr12:120163070-120184243 1853 nt 0.5505
hsa_GCN1L1_0016700 Exon-Exon chr12:120600874-120622690 chr12:120163070-120184887 1917 nt 0.5483
hsa_GCN1L1_0016800 Exon-Exon chr12:120600874-120628203 chr12:120163070-120190400 2020 nt 0.5446
hsa_GCN1L1_0016900 Exon-Exon chr12:120600874-120632513 chr12:120163070-120194710 2051 nt 0.5480
hsa_GCN1L1_0017100 Exon-Exon chr12:120602140-120608125 chr12:120164336-120170321 482 nt 0.5519
hsa_GCN1L1_0017200 Exon-Exon chr12:120602140-120613677 chr12:120164336-120175874 935 nt 0.5465
hsa_GCN1L1_0017300 Exon-Exon chr12:120602140-120622046 chr12:120164336-120184243 1663 nt 0.5460
hsa_GCN1L1_0017500 Exon-Exon chr12:120602450-120615358 chr12:120164646-120177555 959 nt 0.5224
Showing 121 to 130 of 152 entries
Forensic Context

A review consolidating existing research indicates that in various mammalian species, the circGCN1L1 serves as an example where its expression was experimentally abolished using CRISPR/Cas9 genome-editing without affecting the expression of its corresponding linear mRNA [Mehta et al. DOI:10.1016/j.pneurobio.2020.101746].